Sarepta Therapeutics Incorporated operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sarepta Therapeutics Incorporated with three other
companies in this sector in the United States:
Mabvax Therapeutics Holdings Inc
sales of $1.27 million
Intellect Neurosciences, Inc.
Sales fell dramatically in 2015:
Sarepta Therapeutics Incorporated reported sales of $1.25 million
December of 2015.
decrease of 87.2%
versus 2014, when the company's sales were $9.76 million.